Corcept Therapeutics's total assets for Q1 2026 were $814.88M, a decrease of -2.60% from the previous quarter. CORT total liabilities were $176.89M for the fiscal quarter, a -6.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.